For over a century, a quiet agricultural mystery has persisted in mushroom farms across the United States — a disease that resisted every treatment, as if the cure were always aimed at the wrong target. Researchers at the University of Florida have now revealed why: bacterial blotch, long attributed to one or two known pathogens, is in fact the work of more than 17 distinct bacterial species. This discovery reframes a century of failed interventions not as inadequacy, but as the inevitable consequence of misunderstanding complexity — and opens a more honest path toward solutions that match the
Scientists identify 17 bacterial species behind century-old mushroom disease
Single-target treatments fail because they're only addressing part of the problem
Mark
So for a hundred years, growers have been fighting this disease with treatments that don't work. Why didn't anyone figure out it was multiple bacteria sooner?
Mimi
Because they were looking for one culprit. The two well-known pathogens were there, they were prominent, and that's where the attention went. But in a humid indoor environment, multiple species can thrive at once. The tools to sequence DNA and identify all of them at scale are relatively recent.
Luke
How confident are we that these 17 species are actually all causing the disease? Or are some of them just present in the samples?
Mimi
That's a fair question. They used DNA sequencing, chemical profiling, and lab testing to characterize the bacteria and their disease-causing potential. But the source doesn't specify how many of the 17 they've definitively proven cause damage versus how many are just associated with it.
Mark
And the essential oils and beneficial microbes—how far along is that research?
Mimi
Early stages. They're testing them now. The researchers are clear that more work is needed to see how well they perform under real growing conditions. It's not a solution yet.
Luke
So growers still don't have a reliable treatment. They're waiting for the next phase of research.
Mimi
Exactly. The discovery explains why their current treatments fail, which is valuable. But it doesn't solve the problem immediately. It opens the door to solutions.
Mark
What's the financial impact we're talking about here?
Mimi
The source doesn't give specific numbers on losses. It says the disease causes "significant financial losses" and that it's been a "costly challenge" for farms across the U.S., but there's no dollar figure attached.
Luke
That's a gap. Without knowing the scale of the economic damage, it's hard to judge how urgent this research is relative to other agricultural problems.
Mimi
True. But the fact that it's persisted for over a century and affected an entire industry suggests it's substantial.
The Pulse
- White button mushrooms have been quietly hemorrhaging commercial value for over 100 years, with bacterial blotch turning marketable crops into unsellable losses — sometimes not revealing itself until the mushrooms are already on store shelves.
- Treatments have failed repeatedly because they were built on a false premise: that one or two bacterial species were responsible, when in reality more than 17 pathogenic species have been driving the disease all along.
- DNA sequencing, chemical profiling, and lab analysis of damaged mushrooms from southern U.S. facilities shattered the old model, revealing an unexpectedly diverse microbial community — including one bacterial group never before linked to the disease.
- A $7 million USDA-funded research effort spanning multiple universities is now testing plant-based essential oils and beneficial microorganisms as sustainable, broad-spectrum alternatives to the chemical treatments that have consistently fallen short.
- The path forward requires not just new treatments, but entirely new detection frameworks — ones capable of identifying the full range of bacterial threats thriving in the humid, controlled environments where commercial mushrooms are grown.
For over a century, a quiet agricultural mystery has persisted in mushroom farms across the United States — a disease that resisted every treatment, as if the cure were always aimed at the wrong target. Researchers at the University of Florida have now revealed why: bacterial blotch, long attributed to one or two known pathogens, is in fact the work of more than 17 distinct bacterial species. This discovery reframes a century of failed interventions not as inadequacy, but as the inevitable consequence of misunderstanding complexity — and opens a more honest path toward solutions that match the true scale of the problem.
For more than a century, white button mushroom growers across the United States have watched bacterial blotch quietly undermine their harvests. The disease leaves brown and yellow discoloration on mushroom surfaces, stripping commercial value and shortening shelf life — sometimes appearing only after the crop has already reached grocery stores, compounding the financial and reputational damage for producers.
For decades, the scientific consensus held that one primary bacterial pathogen was to blame. Treatments were designed accordingly. They kept failing. Researchers at the University of Florida decided to look more carefully, collecting damaged mushrooms from southern U.S. production facilities and subjecting them to DNA sequencing, chemical profiling, and laboratory analysis. What they found was startling: more than 17 distinct bacterial species are involved in causing the disease — not one, not two. Among them was a bacterial group never previously associated with bacterial blotch at all.
Lead author Sameerika Mudiyanselage, a doctoral student at UF/IFAS, noted that this hidden complexity explains why single-target treatments have always fallen short. When a disease is driven by a diverse community of pathogens, addressing only the most familiar ones leaves the problem largely intact. The humid, controlled indoor environments of commercial mushroom farms, it turns out, are ideal conditions for multiple bacterial species to thrive simultaneously.
Assistant professor Samuel Martins is now leading a broader response, backed by a $7 million USDA grant involving Penn State, the University of Delaware, and UF/IFAS. The team is exploring plant-based essential oils and beneficial microorganisms as alternatives to conventional chemical treatments — approaches that could suppress harmful bacteria more comprehensively while reducing environmental impact. Researchers caution that real-world performance still needs to be validated, but the direction is clear: understanding the full microbial picture is the only way to build treatments that actually hold.
For more than a century, white button mushrooms have carried a stubborn problem that growers have never quite solved. Bacterial blotch appears as brown or yellow spots on the mushroom surface, turning a marketable crop into something no one wants to buy. The disease lowers yields, shortens shelf life, and sometimes doesn't show up until the mushrooms are already on grocery store shelves or in someone's kitchen—a timing that makes it especially costly for farms trying to maintain their reputation.
For decades, scientists believed they understood the culprit: a single bacterial pathogen that caused the damage. Treatments were designed around that assumption. But the treatments kept failing. They worked inconsistently. They didn't stop the disease from coming back. Growers across the United States kept losing money, kept losing harvests, and kept wondering why nothing seemed to work.
Researchers at the University of Florida decided to look harder. They collected damaged mushrooms from production facilities across the southern United States and ran them through DNA sequencing, chemical profiling, and conventional laboratory tests. What they found upended the conventional understanding: the disease wasn't caused by one bacterium or even two. It involved more than 17 different species of pathogenic bacteria working together or independently to damage the crop.
Two well-known pathogens remained prominent in the samples, but the team also detected a surprisingly high level of another bacterial group that had never before been linked to the disease. Sameerika Mudiyanselage, the study's lead author and a doctoral student at UF/IFAS Tropical Research and Education Center, explained that this complexity had been hiding in plain sight. When multiple different microorganisms cause the same disease, identifying which bacteria are responsible, predicting when outbreaks will occur, and developing treatments that actually work all become exponentially harder. Single-target treatments fail because they're only addressing part of the problem.
This discovery helps explain why bacterial blotch has persisted through generations of attempted management. The humid, carefully controlled indoor environments where commercial mushrooms are grown create ideal conditions for multiple bacterial species to thrive. Growers need detection methods that can identify the full range of bacterial threats, not just the famous two.
Samuel Martins, an assistant professor in the UF/IFAS Department of Plant Pathology, is leading a broader effort funded by a $7 million U.S. Department of Agriculture grant involving Penn State, University of Delaware, and UF/IFAS. The team is now testing plant-based essential oils, beneficial microorganisms, and other biological products as alternatives to conventional chemical treatments. Essential oils contain naturally occurring compounds with antimicrobial properties. Beneficial microbes might suppress harmful bacteria or make it harder for disease-causing organisms to establish themselves. These approaches could give growers new tools while reducing their dependence on chemical treatments, though researchers emphasize that more work is needed to see how well these alternatives perform under actual growing conditions.
The goal, Martins said, is to provide growers with practical, science-based solutions that strengthen mushroom farming systems by understanding the full microbial community at work. By recognizing the hidden complexity of bacterial blotch, scientists hope to improve disease detection, develop more reliable treatments, and reduce the crop losses that have burdened mushroom producers for over a century. The findings could ultimately make mushroom farming more resilient, productive, and environmentally sustainable.
Notable Quotes
For years, the industry has struggled with treatments that provide inconsistent results against bacterial blotch. We are developing advanced diagnostics and sustainable solutions to strengthen mushroom farms nationwide.— Samuel Martins, assistant professor, UF/IFAS Department of Plant Pathology
We found more than 17 different species of pathogenic bacteria associated with the disease. While two well-known bacterial pathogens dominated the known disease profile, we also detected a surprisingly high level of another group of bacteria that has not previously been linked to the mushroom disease.— Sameerika Mudiyanselage, lead author and doctoral student, UF/IFAS
Want the full story?
Read the original at Science Daily ↗
Health & Medicine